Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 24.04.2024
AMAG Austria Metall AG
Ranshofen, April 24, 2024
AMAG Austria Metall AG: Challenging environment influences quarterly result
Quarterly performance influenced by lower aluminium price and lower shipment volumes due to partly subdued incoming orders in Q4/2023
Revenue of EUR 335.8 million below the previous year's level due to price and volume factors (Q1/2023: EUR 4 [ … ]
Wed, 24.04.2024
Blue Cap AG
Group revenue in financial year 2023 at EUR 273.3 million, adjusted EBITDA margin of 8.5%
Net asset value (NAV) amounts to EUR 112.3 million as at 31 December 2023
Dividend proposal of EUR 0.65 per share follows proven dividend policy
For 2024, the Executive Board forecasts revenue of EUR 270-290 million and an adjusted EBITDA margin of 8.5-9.5% [ … ]
Wed, 24.04.2024
SURTECO GROUP SE
SURTECO GROUP SE: Good start to the business year 2024 after a difficult year in 2023
Earnings per share in 2023 amount to € -0.79 after € 1.63 in the previous year
Sales for 2024 are projected to be in the range € 860 to 910 million. Adjusted EBITDA is expected between € 85 and 105 million.
Good start to the business year 2024 with an increase [ … ]
Wed, 24.04.2024
Kuros Biosciences AG
Financial Highlights
Direct MagnetOs sales rose by 155% to CHF 13.9 million in Q1 2024 from CHF 5.4 million in Q1 2023; this corresponds to a sequential increase of 21.9% or CHF 2.5 million over Q4 2023
Total Kuros Medical Devices segment sales accelerated to CHF 13.9 million in Q1 2024 from CHF 5.6 million in Q1 2023
Kuros Medical Devices segm [ … ]
Wed, 24.04.2024
u-blox AG
Revenue of CHF 56.0 million
Similar revenue decline in all regions and markets; decline stronger in the connectivity business
EBIT of CHF -20.4 million, EBIT (adjusted) of CHF -18.6 million
Q1 2024 expected to be the trough
Thalwil, Switzerland – 24 April 2024 – u-blox (SIX: UBXN), a global provider of leading positioning and wireless communica [ … ]
Wed, 24.04.2024
Evotec SE
FINANCIAL RESULTS FOR 2023 FULLY MET UPDATED GUIDANCE
PRIORITY RESET TO PROFITABLE GROWTH: SIZE & FOOTPRINT ADJUSTMENTS TO DRIVE EXPECTED ANNUALISED EBITDA IMPROVEMENT GREATER THAN € 40 M
EVOTEC’S REPORTING STRUCTURE WILL CHANGE TO BUSINESS SEGMENTS “SHARED R&D” AND “JUST – EVOTEC BIOLOGICS” STARTING Q1 2024
Hamburg, Germany, 24 April 202 [ … ]
Wed, 24.04.2024
The Stepstone Group
EQS-Media / 24.04.2024 / 06:05 CET/CEST
Press release
Global job market ranking: Germany is the most popular non-English-speaking country
Australia climbs to the top of the country comparison, USA and Canada in 2nd and 3rd place
Germany close behind in 5th place
No. 1 reason for moving to Germany: good job opportunities
Employees want [ … ]
Wed, 24.04.2024
Dexus Finance Pty Limited
Dexus (ASX: DXS)
ASX release
24 April 2024
Appointment of non-executive director
Dexus is pleased to announce the appointment of Peeyush Gupta AM to the Board of Dexus Funds Management Limited (DXFM) as an independent non-executive director, effective 24 April 2024.
Mr Gupta has extensive experience as a non-executive director across financial [ … ]
Tue, 23.04.2024
Laxxon Medical
Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024 New York, 04/23/2024 / 16:40, EST/EDT - EQS Newswire - Laxxon Medical
Laxxon Medical, a leading 3D screen printing platform technology company, announced today its participation in the World Orphan Drug Congress USA 2024, taking place April 23-25, 2024 in Boston, Mas [ … ]
Tue, 23.04.2024
Evotec SE
Hamburg, Germany, 23 April 2024:
The Supervisory Board of Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has appointed Dr Christian Wojczewski as the Company’s new Chief Executive Officer (“CEO”), effective 01 July 2024. The election was unanimous and is the result of an extensive selection process that bega [ … ]